Consequently, for cancer initiation to occur, activation of oncogenes must be accompanied by senescence bypass mediated by inactivation of tumor suppressors such as Rb1—directly or via inactivation of INK4a (CDKN2a)—and p53. Here, CDKN2A is linked to cancer.